The medical field is constantly looking for new ways to innovate. While in other industries various technologies can be used to help companies earn more money, in the medical industry, technologies can be used to save lives. There are many new advancements that have driven the medical field forward. However, the most promising advancement, 3D printing, has shown massive potential. Also known as additive manufacturing, 3D printing is a recent technology that has allowed both hobbyists and manufacturers to produce parts both economically and swiftly.
3D printing is also useful in other fields such as the biomedical engineering space and could possibly disrupt the whole field.
How?
Well, one of the most notable issues in the medical field are high costs. Typically, advanced technologies and treatments are expensive, which may hinder many individuals from obtaining the best medical care. This issue is particularly common in bionics and prosthetics, with data showing that in America, only 15% of amputees can meet the cost of a prosthesis.
This is where 3D printing comes in. Not only does additive manufacturing use less material than the conventional methods, it also much faster. This makes it easier to produce the same products for only a fraction of the cost. For instance, while a traditional prosthetic hand could cost thousands of dollars, a 3D-printed one may go for about $50.
The continuous advancement of technology ensures that these machines are able to print using different materials while printing even faster. Companies that produce prosthetics could manufacture artificial limbs that fit various desires and needs at a significantly lower cost. This would make it easier for amputees to access resources that help make their lives easier.
Additionally, additive manufacturing can also produce 3D-printed organs through a process known as bio printing. This procedure can be used to develop artificial organs that behave, feel and look like real organs, which may in its own way revolutionize the transplantation of organs.
Similar to conventionally produced prosthetics, conventional artificial organs can be costly. This leaves the only other option — human transplants, which involve long wait lists — with research showing that 17 individuals die daily while waiting for an organ transplant. Using bio printing to manufacture organs would not only be much faster but it would also save lives by decreasing the waiting time.
Another issue that affects conventional transplants is compatibility. While the success rates of body-organ-compatibility have improved immensely, 10-15% of patients who have had a transplant done may reject the organ. Bio printing replacement organs can be done using a patient’s own cells, which eliminates organ rejection by producing an organ that is a perfect genetic match.
Aside from 3D printing, many other biotech developments are being brought to market. For example, Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) has introduced an advanced imaging system that is expected to make it easier for surgeons to see and remove cancerous cells from patients’ bodies.
NOTE TO INVESTORS: The latest news and updates relating to Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) are available in the company’s newsroom at https://ibn.fm/IMEXF
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
Enormous resources are being channeled into studying different ways to support the immune system in its fight…
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…
David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…
Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…
High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…